Chronic Urticaria

Chronic Urticaria is a persistent inflammatory skin disorder characterized by recurrent wheals, angioedema, and intense pruritus lasting longer than six weeks. Unlike acute allergic reactions, this condition often arises from complex immune dysregulation rather than a clearly identifiable trigger. As a clinically significant topic in every major Dermatology Conference, this session explores the evolving understanding of mast cell activation, autoimmune pathways, and targeted biologic therapies that are transforming disease management. Closely associated with chronic hives disorders, chronic urticaria demands a structured diagnostic framework and individualized therapeutic approach to improve long-term patient outcomes.

The session examines underlying mechanisms such as histamine release, IgE-mediated pathways, and autoantibody involvement in spontaneous urticaria. Differentiation between chronic spontaneous urticaria and inducible subtypes—including cold, pressure, cholinergic, and solar variants—is emphasized for accurate classification. Participants will review diagnostic strategies that prioritize clinical assessment while avoiding unnecessary extensive testing.

Treatment algorithms focus on stepwise management, beginning with second-generation antihistamines and escalating to higher doses or adjunctive therapies when needed. Biologic agents targeting IgE and inflammatory mediators have significantly altered the therapeutic landscape for refractory cases. Emerging research on mast cell stabilization and immune modulation continues to expand available options.

Quality-of-life impact remains a central theme, as chronic itching, sleep disruption, and unpredictability of flare-ups contribute to psychological stress and functional impairment. Counseling strategies, patient education, and lifestyle modifications are addressed to improve adherence and symptom control. Special attention is given to angioedema management and recognizing red flags that require further systemic evaluation.

By integrating immunologic science with practical clinical management, this session equips dermatologists with evidence-based strategies to control chronic urticaria effectively. The goal is to reduce disease burden, prevent recurrence, and enhance overall patient well-being through targeted and sustained therapeutic interventions.